Hospitalized community-acquired pneumonia due to Streptococcus pneumoniae: Has resistance to antibiotics decreased?

Chest

Volumn 130, Issue 3, 2006, Pages 800-806

  Vallès, Xavier ^a   Marcos, Angeles ^a   Pinart, Mariona ^a   Piñer, Raquel ^a   Marco, Francesc ^a   Mensa, Josep Maria ^a   Torres, Antoni ^a  

^a HOSPITAL CLÍNIC   (Spain)

Author keywords

Antimicrobial resistance; Community acquired pneumonia; Mortality; Serotype; Streptococcus pneumoniae

Indexed keywords

ANTIBIOTIC AGENT; BETA LACTAM ANTIBIOTIC; CEFTRIAXONE; CEPHALOSPORIN DERIVATIVE; CIPROFLOXACIN; CLINAFLOXACIN; CORTICOSTEROID; ERYTHROMYCIN; GATIFLOXACIN; GREPAFLOXACIN; IMIPENEM; LEVOFLOXACIN; MACROLIDE; OFLOXACIN; PENICILLIN G; QUINOLONE DERIVATIVE; SPARFLOXACIN; VANCOMYCIN;

ADOLESCENT; ADULT; AGED; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL STRAIN; COMMUNITY ACQUIRED PNEUMONIA; COMORBIDITY; CONFIDENCE INTERVAL; CORTICOSTEROID THERAPY; FEMALE; FOLLOW UP; GENDER; HOSPITALIZATION; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MORTALITY; NONHUMAN; PLEURA EFFUSION; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; SEROTYPE; SPAIN; STREPTOCOCCUS PNEUMONIA; STREPTOCOCCUS PNEUMONIAE;

EID: 33748882326     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.130.3.800     Document Type: Article

References (29)

1. Marrie TJ. Pneumococcal pneumonia: epidemiology and clinical features. Semin Respir Infect 1999; 14:227-236
2. Andrews J, Nadjm B, Gant V, et al. Community-acquired pneumonia. Curr Opin Pulm Med 2003; 9:175-180
3. File TM Jr. Streptococcus pneumoniae and community-acquired pneumonia: a cause for concern. Am J Med 2004; 117(suppl 3A):39S-50S
4. Jackson ML, Neuzil KM, Thompson WW, et al. The burden of community-acquired pneumonia in seniors: results of a population-based study. Clin Infect Dis 2004; 39:1642-1650
5. Boldt MD, Kiresuk T. Community-acquired pneumonia in adults. Nurse Pract 2001; 26:14-23
6. Adam D. Global antibiotic resistance in Streptococcus pneumoniae. J Antimicrob Chemother 2002; 50(suppl):1-5
7. Aspa J, Rajas O, Rodriguez de Castro F, et al. Current perspectives on Streptococcus pneumoniae antibiotic resistance, with particular reference to isolates from Spain. Clin Pulm Med 2005; 12:210-219
8. Bauer T, Ewig S, Marcos MA, et al. Streptococcus pneumoniae in community-acquired pneumonia: how important is drug resistance? Med Clin North Am 2001; 85:1367-1379
9. Alfageme I, Aspa J, Bello S, et al. Normatives para el diagnóstico y el tratamiento de la neumonía adquirida en la comunidad. Sociedad Española de Neumología y Cirugía Torácica (SEPAR). Arch Bronconeumol 2005; 41:272-289
10. Ewig S, Ruiz M, Torres A, et al. Pneumonia acquired in the community through drug-resistant Streptococcus pneumoniae. Am J Respir Crit Care Med 1999; 159:1835-1842
11. Murray TJ, Washington JA. Microscopic and bacteriologic analysis of expectorated sputum. Mayo Clin Proc 1975; 50:339-344
12. Marcos MA, Jimenez de Anta MT, de la Bellacasa JP, et al. Rapid urinary antigen test for diagnosis of pneumococcal community-acquired pneumonia in adults. Eur Respir J 2003; 21:209-214
13. National Committee for Clinical Laboratory Standards. Methods for dilution antimicrobial susceptibility test for bacteria that grow aerobically. 5th ed. Wayne, PA: NCCLS, 2000; M7-A5
14. Vila J, Ribera A, Marco F, et al. Activity of clinafloxacin, compared with six other quinolones, against Acinetobacter baumannii clinical isolates. J Antimicrob Chemother 2002; 49:471-477
15. Sierra J, Cabeza J, Ruiz-Chaler M, et al. The selection of resistance to and the mutagenicity of different fluoroquinolones in Staphylococcus aureus and Streptococcus pneumoniae. Clin Microbiol Infect 2005; 11:750-758
16. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility testing. Wayne, PA: NCCLS, 2001; M100-S1
17. Cabre M, Bolivar I, Pera G. Factors influencing length of hospital stay in community-acquired pneumonia: a study in 27 community hospitals. Epidemiol Infect 2004; 132:821-829
18. Aspa J, Rajas O, Rodriguez DC, et al. Drug-resistant pneumococcal pneumonia: clinical relevance and related factors. Clin Infect Dis 2004; 38:787-798
19. Fenoll A, Jado I, Vicioso D, et al. Evolution of Streptococcus pneumoniae serotypes and antibiotic resistance in Spain: update (1990 to 1996). J Clin Microbiol 1998; 36:3447-3454
20. Blanco-Quiros A, Giménez-Sánchez F, Asensi-Botet F, et al. Vaccination schedule of the Spanish Association of Pediatrics: recommendations 2004. An Pediatr (Barc) 2004; 60:468-472
21. Fenoll A, Asensio G, Jado I, et al. Antimicrobial susceptibility and pneumococcal serotypes. J Antimicrob Chemother 2002; 50(Suppl S2):13-19
22. Marco F, Bouza E, Garcia-De-Lomas J, et al. Streptococcus pneumoniae in community-acquired respiratory tract infections in Spain: the impact of serotype and geographical, seasonal and clinical factors on its susceptibility to the most commonly prescribed antibiotics. The Spanish Surveillance Group for Respiratory Pathogens. J Antimicrob Chemother 2000; 46:557-564
23. Feikin DR, Feldman C, Schuchat A, et al. Global strategies to prevent bacterial pneumonia in adults with HIV disease. Lancet Infect Dis 2004; 4:445-455
24. Jordano Q, Falco V, Almirante B, et al. Invasive pneumococcal disease in patients infected with HIV: still a threat in the era of highly active antiretroviral therapy. Clin Infect Dis 2004; 38:1623-1628
25. Agusti C, Rano A, Filella X, et al. Pulmonary infiltrates in patients receiving long-term glucocorticoid treatment etiology, prognostic factors, and associated inflammatory response. Chest 2003; 123:488-498
26. Pallares R, Linares J, Vadillo M, et al. Resistance to penicillin and cephalosporin and mortality from severe pneumococcal pneumonia in Barcelona, Spain. N Engl J Med 1995; 333:474-480
27. Yu VL, Chiou CC, Feldman C, et al. An international prospective study of pneumococcal bacteremia: correlation with in vitro resistance, antibiotics administered, and clinical outcome. Clin Infect Dis 2003; 37:230-237
28. Falco V, Almirante B, Jordano Q, et al. Influence of penicillin resistance on outcome in adult patients with invasive pneumococcal pneumonia: is penicillin useful against intermediately resistant strains? J Antimicrob Chemother 2004; 54:481-488
29. Niederman MS. Review of treatment guidelines for community-acquired pneumonia. Am J Med 2004; 117(suppl 3A):51S-57S